Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Bone morphogenetic protein 8B (BMP8B)
- Target
- BMP8B
- Molecular classification
- Growth factor, Cytokine, Ligand of the TGF-β receptor family, Member of the TGF-β superfamily
01
Overview
Bone morphogenetic protein 8B is a secreted growth factor of the TGF-β superfamily, involved in embryonic development, bone and cartilage formation, cell differentiation, and tissue regeneration. It shares strong sequence homology with BMP7 and BMP5, and exerts its effects via binding to cell-surface TGF-β receptors, activating Smad-mediated intracellular signaling. BMP8B has been implicated in brown adipose tissue thermogenesis and may play roles in skeletal disorders, wound healing, and muscle regeneration. Recombinant BMP8B is under investigation for use in regenerative medicine, but no drugs directly target BMP8B clinically. Safety data for BMP8B are limited, but general concerns include potential ectopic bone formation and immunogenicity.
- Other names
- BMP8BBMP-8BBone morphogenetic protein 8BBMP8BMP-8OP-2Osteogenic protein 2OP2
02
Mechanism of action
Drug candidates or recombinant BMP8B would act by binding to TGF-β receptors, activating Smad signaling, resulting in the induction of bone/cartilage formation, tissue regeneration, and modulation of cell fate and differentiation
03
Biological functions
Bone and cartilage formationRegulation of cell differentiation and proliferationExtracellular matrix synthesisThermogenesis in brown adipose tissueEmbryonic developmentTissue regeneration and repair
04
Disease associations
Skeletal disorders (potential association based on its role in bone/cartilage formation)Muscle injury and regeneration (indirect evidence from its broader regenerative role)Laryngeal tuberculosis (reported association, likely mechanistic/pathophysiological)Silo filler’s disease (reported association, details unclear)Possible involvement in pancreatic cancer (expression may be downregulated)Possible implications in wound healing and chronic tissue damage via regenerative processes
05
Safety considerations
Off-target bone formation (heterotopic ossification)Immunogenicity of recombinant proteinsDose-dependent adverse tissue responsesBMP8B-specific safety data are lacking
06
Biomarkers
No established clinical biomarkers specific for BMP8B for patient selection or efficacy monitoringBMP8B expression may potentially serve as a tissue regeneration or bone metabolism marker in research
Beyond the preview
Go deeper on Bone morphogenetic protein 8B (BMP8B).
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Clinical trials
Full profile accessFollow the clinical studies evaluating therapies directed at this target.
- Trial design
- Status
- Readouts
Competitive landscape
Full profile accessCompare approaches across drug candidates, modalities, and indications.
- Programs
- Modalities
- Indications
Literature & evidence
Full profile accessInvestigate the research and source evidence behind target biology and development.
- Publications
- Sources
- Analysis
Patents
Full profile accessExplore patent activity around therapies and technologies addressing this target.
- Patents
- Assignees
- Technologies
Research & analysis
Full profile accessConnect target biology, drug development, and emerging evidence in your research.
- Biology
- Development news
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Bone morphogenetic protein 8B (BMP8B).